Evidence map›Paper›PMID 22172309›Full record

ArticleBioorganic & medicinal chemistry2012

Novel bioactive metabolites of dipyrone (metamizol).

Tobias Rogosch, Christian Sinning, Agnes Podlewski, Bernhard Watzer, Joel Schlosburg, Aron H Lichtman, Maria G Cascio, Tiziana Bisogno, Vincenzo Di Marzo, Rolf Nüsing and 1 more

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 4 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CBBritish journal of pharmacology · 2020
    Article
  19. A Guide to Targeting the Endocannabinoid System in Drug Design.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Tobias RogoschZentrum für Kinder- und Jugendmedizin, Philipps-Universität, Marburg, Germany.
Christian Sinning
Agnes Podlewski
Bernhard Watzer
Joel Schlosburg
Aron H Lichtman
Maria G Cascio
Tiziana Bisogno
Vincenzo Di Marzo
Rolf Nüsing
Peter Imming
Istituto di Chimica Biomolecolare · ITPhilipps University of Marburg · DEMartin Luther University Halle-Wittenberg · DEVirginia Commonwealth University · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
SYNTHESIS OF SR141716A AND ANANDAMIDE ANALOGSP01DA009789 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI LICHTMAN, ARON H · 1995 to 2013
$11.6M
STRUCTURAL STUDIES OF FAAHP01DA017259 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2004 to 2013
$10.6M
Endocannabinoid Modulation of PruritusF31DA026279 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI SCHLOSBURG, JOEL EVAN · 2009 to 2009
$30k
NIDA NIH HHS F31 DA026279NIDA NIH HHS F31DA026279NIDA NIH HHS P01 DA009789NIDA NIH HHS P01DA009789NIDA NIH HHS P01 DA017259NIDA NIH HHS P01DA017259NIDA NIH HHS T32 DA007027NIDA NIH HHS T32DA007027
6 · The paper itself

Abstract

Dipyrone is a common antipyretic drug and the most popular non-opioid analgesic in many countries. In spite of its long and widespread use, molecular details of its fate in the body are not fully known. We administered dipyrone orally to mice. Two unknown metabolites were found, viz. the arachidonoyl amides of the known major dipyrone metabolites, 4-methylaminoantipyrine (2) and 4-aminoantipyrine (3). They were identified by ESI-LC-MS/MS after extraction from the CNS, and comparison with reference substances prepared synthetically. The arachidonoyl amides were positively tested for cannabis receptor binding (CB(1) and CB(2)) and cyclooxygenase inhibition (COX-1 and COX-2 in tissues and as isolated enzymes), suggesting that the endogenous cannabinoid system may play a role in the effects of dipyrone against pain.

Indexed as

Administration, OralAminopyridinesAmpyroneAnimalsCentral Nervous SystemChromatography, High Pressure LiquidCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsDipyroneEnzyme ActivationMiceMice, Inbred C57BLReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Reference Standards4-methylaminopyridineAminopyridinesAmpyroneCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsDipyroneReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2

Identifiers

PMID22172309
PMCPMC3248997
OpenAlexW2019236523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.